Antimutagenic potency of chlorophyllin in the salmonella assay and its correlation with binding constants of mutagen‐inhibitor complexes
- 1 January 1993
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 22 (3) , 164-171
- https://doi.org/10.1002/em.2850220309
Abstract
Chlorophyllin (CHL) is a water-soluble salt of chlorophyll that exhibits antimutagenic activity in short-term genotoxicity assays and inhibits carcinogen-DNA binding in vivo. The antimutagenic potency of CHL was studied against several structurally related heterocyclic amines using the Salmonella assay. The mutagens included 2-amino-3-methylimidazo[4,5,-f]-quinoline (IQ) and seven related IQ-type compounds, and 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and three additional non-IQ-type compounds. No relationship was observed between mutagenic potency (revertants/ng mutagen) and antimutagenic potency when expressed in terms of the CHL dose/plateinhibiting mutagenicity by 50 percent (l50). However, a correlation was observed between mutagenic potency and the mole ratio of CHL to mutagen giving 50% inhibition (MR50), with most mutagens requiring several hundredfold to several thousandfold molar excess of CHL for inhibition. In spectrophotometric studies, CHL formed noncovalent molecular complexes with the heterocyclic amines, with binding constants in the range 3–13 x 103 M−1. Binding constants were inversely correlated with l50 and MR50 values, i.e., with increasing strength of complex formation less CHL/plate and a lower mole ratio of CHL to mutagen was required to inhibit mutagenicity. The results support an inhibitory mechanism in which chlorophylls operate as “interceptor molecules,” interacting with carcinogens and mutagens directly and limiting their bioavailability.Keywords
This publication has 19 references indexed in Scilit:
- Inhibition of 2-amino-3-methylimidazo[4.5-f] (IQ)-DNA binding by chlorophyllin: studies of enzyme inhibition and molecular complex formationCarcinogenesis: Integrative Cancer Research, 1992
- Protection by chlorophyllin against the covalent binding of 2-amino-3-methylimidazo[4,5-f]qiiinoline (IQ) to rat liver DNACarcinogenesis: Integrative Cancer Research, 1992
- Chlorophyllin is both a positive and negative modifier of mutagenicityMutagenesis, 1992
- Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the salmonella mutagenicity assayCarcinogenesis: Integrative Cancer Research, 1991
- Antimutagenicity studies of chlorophyllin using the Salmonella arabinose-resistant assay systemMutation Research Letters, 1991
- Quantitative structure‐activity relationships of heterocyclic amine mutagens formed during the cooking of foodEnvironmental and Molecular Mutagenesis, 1991
- Antimutagens and anticarcinogens: A survey of putative interceptor moleculesEnvironmental and Molecular Mutagenesis, 1990
- Role of hemin in the inhibition of mutagenic activity of 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and other aminoazaarenesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989
- Comparative antimutagenicity of chlorophyllin and five other agents against aflatoxin B1‐induced reversion in Salmonella typhimurium strain TA98Teratogenesis, Carcinogenesis, and Mutagenesis, 1988
- Antimutagenic activity of some naturally occurring compounds towards cigarette-smoke condensate and benzo[a]pyrene in the Salmonella/microsome assayMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1985